- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02679599
Increasing Exercise and Decreasing Sedentary Behavior Among Patients in a Cardiac Rehabilitation Clinic
1 september 2017 uppdaterad av: Andrew Busch, The Miriam Hospital
Cardiac rehabilitation patients often fail to exercise as prescribed on days they are not attending rehabilitation and there is a steep drop off in exercise following rehabilitation completion.
Moreover, little is known about the amount of time that cardiac rehabilitation patients spend in sedentary behavior, which is associated with increased risk of cardiovascular morbidity and mortality, independent of time spent in exercise.
This pilot study aims to test acceptability, feasibility, and preliminary efficacy of a smartphone application (B-MOBILE-CARDIAC) for increasing time spent in moderate-to-vigorous intensity physical activity accumulated in bouts of at least 10 minutes in duration (i.e.
bout-related MVPA) and decrease time spent in sedentary behavior.
Up to 32 patients will be recruited, enrolled, and randomized during the first 2 weeks of cardiac rehabilitation to either: 1) B-MOBILE-CARDIAC plus cardiac rehabilitation or 2) cardiac rehabilitation alone.
Participants will complete 7 days of objective activity monitoring to measure daily minutes spent in bout-related MVPA and sedentary behavior (primary outcomes) at baseline, mid-rehabilitation (6 weeks), end of cardiac rehabilitation (12 weeks), and 4-week follow-up (16 weeks).
At these same time points, participants will complete questionnaires assessing sedentary behavior, MVPA, exercise tolerance, health-related quality of life, mood, and affect.
At baseline and end of cardiac rehabilitation participants will undergo a blood draw to measure cardiometabolic and inflammatory risk factors and complete a test of cognitive functioning.
Feasibility and acceptability of the B-MOBILE-CARDIAC application will be assessed at the 4-week follow-up.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
23
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Rhode Island
-
Providence, Rhode Island, Förenta staterna, 02903
- The Miriam Hospital
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 75 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- within one week of starting rehabilitation,
- self-report that they can walk for 10 minutes without assistance from others,
- were approved for and are planning to complete 12 weeks of rehabilitation,
- own a compatible Android phone or are willing to be taught to use one by study staff;
- no evidence of cognitive impairment
- able to speak and read English,
- aged 18-75 years,
- no known nickel allergy, and
- willing to follow the protocol (e.g., carry a smartphone for 16 weeks).
Exclusion Criteria:
-
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Övrig: Cardiac rehabilitation as usual
Participants will receive cardiac rehabilitation as usual (i.e., as offered in the clinical setting).
|
|
|
Experimentell: Cardiac rehabilitation plus B-MOBILE-CARDIAC smartphone app
Participants will receive cardiac rehabilitation as usual, plus access to the B-MOBILE-CARDIAC smartphone application through 4 weeks post-rehabilitation.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Change in objectively measured time engaged in sedentary behavior
Tidsram: Change from Baseline to 12 weeks (i.e., end of rehabilitation)
|
Change from Baseline to 12 weeks (i.e., end of rehabilitation)
|
|
Change in objectively measured time engaged in moderate-to-vigorous intensity physical activity
Tidsram: Change from Baseline to 12 weeks (i.e., end of rehabilitation)
|
Change from Baseline to 12 weeks (i.e., end of rehabilitation)
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Self-reported sedentary behavior (The Sedentary Behavior Questionnaire)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Self-reported sedentary behavior (SIT-Q-7d Questionnaire)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Self-reported physical activity (Paffenbarger Physical Activity Questionnaire)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Self-reported exercise tolerance (Duke activity status index)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Health related quality of life (SF-12 Health Survey)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Depressed Mood (Patient Health Questionnaire-9)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Affect (Positive Affect Negative Affect Scales)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Cognitive status (Montreal Cognitive Assessment score)
Tidsram: Baseline and 12 weeks (i.e., end of rehabilitation).
|
Baseline and 12 weeks (i.e., end of rehabilitation).
|
|
Smartphone application acceptability (study specific scale)
Tidsram: Baseline through 16 weeks.
|
Baseline through 16 weeks.
|
|
Change in objectively measured time engaged in sedentary behavior
Tidsram: Change from Baseline to 16 weeks
|
Change from Baseline to 16 weeks
|
|
Change in objectively measured time engaged in moderate-to-vigorous intensity physical activity
Tidsram: Change from Baseline to 16 weeks
|
Change from Baseline to 16 weeks
|
|
Lipid profile
Tidsram: Baseline and 12 weeks (i.e., end of rehabilitation)
|
Baseline and 12 weeks (i.e., end of rehabilitation)
|
|
C-reactive protein
Tidsram: Baseline and 12 weeks (i.e., end of rehabilitation)
|
Baseline and 12 weeks (i.e., end of rehabilitation)
|
|
haemoglobin A1c (HbA1C)
Tidsram: Baseline and 12 weeks (i.e., end of rehabilitation)
|
Baseline and 12 weeks (i.e., end of rehabilitation)
|
|
Blood pressure
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Waist circumference
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
|
Body Mass Index (kg/m^2, weight in kilograms, height in meters)
Tidsram: Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Baseline, 6 weeks, 12 weeks (i.e., end of rehabilitation), and 16 weeks.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 mars 2016
Primärt slutförande (Faktisk)
1 april 2017
Avslutad studie (Faktisk)
1 april 2017
Studieregistreringsdatum
Först inskickad
2 februari 2016
Först inskickad som uppfyllde QC-kriterierna
5 februari 2016
Första postat (Uppskatta)
10 februari 2016
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
6 september 2017
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
1 september 2017
Senast verifierad
1 september 2017
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 215615
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .